NCT00651079View on ClinicalTrials.gov

GSK1247303 First Time in Human Study

PHASE1TerminatedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GSK1247303

Trial Locations (1)

66211

GSK Investigational Site, Overland Park

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00651079 - GSK1247303 First Time in Human Study | Biotech Hunter | Biotech Hunter